A patch circuit dissection of opioid addiction
阿片类药物成瘾的补丁电路剖析
基本信息
- 批准号:10591745
- 负责人:
- 金额:$ 19.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-01 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:AmericanAnalgesicsAxonBehaviorBehavioralBiological AssayBrainCOVID-19 pandemicCalciumCellsCharacteristicsClinical ResearchConsumptionCorpus striatum structureDepressed moodDesire for foodDissectionDopamine ReceptorDorsalExtinctionFiberFoundationsGene ExpressionGeneticGoalsHealthImmediate-Early GenesInterventionIntoxicationIslandKnowledgeLabelMaintenanceMeasuresMediatorMonitorNaloxoneNegative ReinforcementsNegative ValenceNervous SystemNeuroanatomyNeurobiologyNeuronsNucleus AccumbensOpiate AddictionOpioidOpioid ReceptorOpticsOutputPathologicPathway interactionsPatternPharmaceutical PreparationsPhasePhotometryPopulationPositive ReinforcementsPositive ValencePre-Clinical ModelPropertyPsychological reinforcementPublic HealthRabiesRelapseRewardsRoleSelf AdministrationSourceSubstance Use DisorderTechniquesTrainingVentral StriatumViralVirusWithdrawalWithdrawal SymptomWorkaddictionbehavioral economic analysiscell typecombatconditioned place preferencedrug abstinencedrug rewardgenetic manipulationinsightlensmedication-assisted treatmentmotivated behaviormouse geneticsmu opioid receptorsneuroimagingnovel therapeuticsopioid abuseopioid epidemicopioid mortalityopioid overdoseopioid useopioid use disorderopioid withdrawaloptogeneticspharmacologicpreclinical studyprodynorphinreceptor expressionrecruitresponsestriosome
项目摘要
PROJECT SUMMARY/ABSTRACT
The opioid crisis remains a major health concern with millions of Americans addicted to opioid drugs and
thousands of opioid related deaths per year. The sad reality is that while medication assisted therapies are highly
effective, relapse rates remain high. More understanding is needed into the neurobiology and circuits of opioid
addiction to identify new therapies. Opioids exert their rewarding and addictive effects through action at the mu
opioid receptor (MOR). The MOR is expressed widely throughout the nervous system including regions
associated with drug reward such as the nucleus accumbens. It is present in a peculiar neuroanatomic
organization referred to as “patch” or “striosome,” with dense regional expression situated in a network of islands
throughout dorsal striatum and nucleus accumbens. The region outside of these islands is referred to as matrix.
The functional relevance of this level of neuroanatomic organization is mysterious and its consequence for opioid
use disorders is almost completely unknown. While the direct and indirect pathway of striatal organization has
revealed critical insights into motivated behavior and pathologic changes associated with substance use
disorders, it remains incomplete especially in regions of the ventral striatum such as the nucleus accumbens. The
neuroanatomy of “patch” vs “matrix,” and the cell types contained within each compartment, opens the
possibility for a revived lens through which to look at the functional organization of the nucleus accumbens in
motivated behavior and addiction. Recently, the power of mouse genetics revealed two separate populations of
direct pathway medium spiny neurons housed within MOR positive patch networks. Further work has shown
that while one population encodes positive valence and positive reinforcement, the other encodes negative
valence and negative reinforcement, challenging the traditional dogma of the direct pathway. This proposal
resubmission begins to define a role for these cell populations in preclinical models of opioid abuse, investigating
the properties of patches in the valence of opioids and withdrawal, opioid consumption, maintenance, extinction
and reinstatement. Input and output circuitry will be defined in each patch cell type within the nucleus
accumbens. The work will combine opioid self-administration, behavioral economic analysis, viral
neuroanatomic techniques, optogenetic and chemogenetic manipulations and cell type neuroimaging with fiber
photometry. This work will be among the first to study MOR (+) patch circuits in the context of opioid use
disorder. Through this new lens of functional organization, insights can be revealed that could lead to new
therapies in treating the devastating health and societal impact of opioid use disorders.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason M Tucciarone其他文献
Jason M Tucciarone的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason M Tucciarone', 18)}}的其他基金
Mapping the Inputs onto Neocortical Chandelier Cells
将输入映射到新皮质枝形吊灯细胞上
- 批准号:
8732703 - 财政年份:2012
- 资助金额:
$ 19.27万 - 项目类别:
Mapping the Inputs onto Neocortical Chandelier Cells
将输入映射到新皮质枝形吊灯细胞上
- 批准号:
8456478 - 财政年份:2012
- 资助金额:
$ 19.27万 - 项目类别:
Mapping the Inputs onto Neocortical Chandelier Cells
将输入映射到新皮质枝形吊灯细胞上
- 批准号:
8656291 - 财政年份:2012
- 资助金额:
$ 19.27万 - 项目类别:
相似海外基金
Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
- 批准号:
10641500 - 财政年份:2023
- 资助金额:
$ 19.27万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 19.27万 - 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 19.27万 - 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
- 批准号:
10638278 - 财政年份:2023
- 资助金额:
$ 19.27万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 19.27万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 19.27万 - 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
- 批准号:
22K19602 - 财政年份:2022
- 资助金额:
$ 19.27万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
- 批准号:
10512672 - 财政年份:2022
- 资助金额:
$ 19.27万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10721752 - 财政年份:2022
- 资助金额:
$ 19.27万 - 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
- 批准号:
10821681 - 财政年份:2022
- 资助金额:
$ 19.27万 - 项目类别:














{{item.name}}会员




